Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-04-23 00:00:00 ET · period of report 2024-04-22 · accession 0001510281-24-000252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-04-23 | 2024-04-22+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.14 | +50.2K | 2.74M | +2% | +$659.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-23 | P | A | 48,203 | $13.15 | 2,787,195 | I - | — | — | |
| 2 | Common | Common Stock | 2024-04-22 | P | A | 2,022 | $12.88 | 2,738,992 | I - | — | — |